Company Profiles

driven by the PitchBook Platform

Intervention Insights

Description

Provider of cancer therapeutic information services to assist community oncologists. The company analyzes cancerous tissues and generates a genomic picture of genes and corresponding molecular pathways helping oncology care team to access and consider medical evidence to support the molecular diagnostics and targeted therapeutics.

2009

Founded

PRIVATE

Status

11-50

Employees

Series B

Latest Deal Type

$3.5M

Latest Deal Amount

$13.2M

Total Amount Raised

Description

Provider of cancer therapeutic information services to assist community oncologists. The company analyzes cancerous tissues and generates a genomic picture of genes and corresponding molecular pathways helping oncology care team to access and consider medical evidence to support the molecular diagnostics and targeted therapeutics.

Website:

www.interventioninsights.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Information Services (B2C)

Other Industries

Other Healthcare Services

Primary Office

1601 Trapelo Road Suite 255 Cambridge, MA 02142United States +1 (617) 250-7572
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Intervention Insights's full profile, request a free trial.

    Intervention Insights Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Intervention Insights Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Intervention Insights Investors (7)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Ann Arbor SPARKAccelerator/IncubatorMinority000 0000000 0000
    BeringeaPE/BuyoutMinority000 0000000 0000
    Biosciences Research and Commercialization CenterVenture CapitalMinority000 0000000 0000
    Chrysalis VenturesVenture CapitalMinority000 0000000 0000
    Hopen Life Science VenturesVenture CapitalMinority000 0000000 0000
    Ann Arbor SPARK Accelerator/Incubator
    Beringea PE/Buyout
    Biosciences Research and Commercialization Center Venture Capital
    Chrysalis Ventures Venture Capital
    Hopen Life Science Ventures Venture Capital

    Intervention Insights Executive Team (5)

    NameTitleBoard
    Seat
    Contact
    Info
    Dennis ReillyChief Financial Officer
    Russell Ingersoll Ph.DChief Product Officer
    Russ Clark JDVice President
    Clynt TaylorChief Executive Officer & Board Member
    Alex GinzburgVice President, Technology
    Dennis Reilly Chief Financial Officer
    Russell Ingersoll Ph.D Chief Product Officer
    Russ Clark JD Vice President
    Clynt Taylor Chief Executive Officer & Board Member
    Alex Ginzburg Vice President, Technology

    Intervention Insights Board Members (5)

    NameRepresentingRoleSinceContact
    Info
    Charlie CrawfordChrysalis VenturesAssociate000 0000
    Clynt TaylorSelfChief Executive Officer & Board Member000 0000
    Mark OlesnavageHopen Life Science VenturesCo-Founder & Managing Director000 0000
    Michael GrossBeringeaManaging Director000 0000
    Wright SteenrodChrysalis VenturesPartner000 0000
    Charlie Crawford Associate Chrysalis Ventures
    Clynt Taylor Chief Executive Officer & Board Member Self
    Mark Olesnavage Co-Founder & Managing Director Hopen Life Science Ventures
    Michael Gross Managing Director Beringea
    Wright Steenrod Partner Chrysalis Ventures
    Request full access to PitchBook